Axon guidance molecules in immunometabolic diseases

Inflamm Regen. 2022 Jan 19;42(1):5. doi: 10.1186/s41232-021-00189-0.

Abstract

The global prevalence of metabolic diseases, such as obesity, diabetes, and atherosclerosis, is rapidly increasing and has now reached epidemic proportions. Chronic tissue inflammation is a characteristic of these metabolic diseases, indicating that immune responses are closely involved in the pathogenesis of metabolic disorders. However, the regulatory mechanisms underlying immunometabolic crosstalk in these diseases are not completely understood. Recent studies have revealed the multifaceted functions of semaphorins, originally identified as axon guidance molecules, in regulating tissue inflammation and metabolic disorders, thereby highlighting the functional coupling between semaphorin signaling and immunometabolism. In this review, we explore how semaphorin signaling transcends beyond merely guiding axons to controlling immune responses and metabolic diseases.

Keywords: Atherosclerosis; Chronic inflammation; Diabetes; Neuropilins; Obesity; Plexins; Semaphorins.

Publication types

  • Review